OTC Markets OTCQB - Delayed Quote USD
Northwest Biotherapeutics, Inc. (NWBO)
0.2800
+0.0030
+(1.08%)
At close: May 9 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2017) | Current Year (2017) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.2 | -0.85 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2017) | Current Year (2017) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 3/31/2016 | 6/30/2016 | 9/30/2016 | 12/31/2016 |
|---|---|---|---|---|
| EPS Est. | -0.25 | -0.29 | -0.12 | -0.19 |
| EPS Actual | -0.06 | -0.2 | -0.25 | -0.34 |
| Difference | 0.19 | 0.09 | -0.13 | -0.15 |
| Surprise % | 76.00% | 31.10% | -112.00% | -78.95% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2017) | Current Year (2017) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2017) | Current Year (2017) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NWBO | -- | -- | -- | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Downgrade | Oppenheimer: Outperform to Perform | 3/12/2014 |
Related Tickers
CVM CEL-SCI Corporation
0.2468
-3.14%
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%
BBIO BridgeBio Pharma, Inc.
34.17
-1.95%
CYTK Cytokinetics, Incorporated
31.70
-2.42%
SGMO Sangamo Therapeutics, Inc.
0.7002
-2.72%
RCKT Rocket Pharmaceuticals, Inc.
6.99
-0.71%
CYDY CytoDyn Inc.
0.4000
+0.05%
KROS Keros Therapeutics, Inc.
13.65
-2.64%
ATNM Actinium Pharmaceuticals, Inc.
1.4800
+3.50%
APLS Apellis Pharmaceuticals, Inc.
17.30
-2.86%